Storage Condition
Refer MSDS for complete information
Synonyms
(4S,4aR,5S,5aR,6R,12aS)-3,5,10,12,12a-pentahydroxy-6-methyl-4-(methyl(nitroso)amino)-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide-D3
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
D2-N-Nitroso desmethyldoxycycline is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
D2-N-Nitroso desmethyldoxycycline usage and description
D2-N-Nitroso desmethyldoxycycline is a derivative of the tetracycline antibiotic doxycycline. It is a potent antimicrobial agent that has shown efficacy against a wide range of Gram-positive and Gram-negative bacteria. The compound has also been shown to be effective against certain types of cancer cells, making it a potential candidate for cancer treatment.
D2-N-Nitroso desmethyldoxycycline works by inhibiting bacterial protein synthesis through binding to the 30S ribosomal subunit. The compound also exhibits anticancer properties by inducing cancer cell death through the generation of reactive oxygen species (ROS) and DNA damage.
The use of D2-N-Nitroso desmethyldoxycycline is still in the experimental stage and has not been approved for human use. However, preclinical studies have shown promising results, indicating its potential as a therapeutic agent.
It is important to note that D2-N-Nitroso desmethyldoxycycline is a highly reactive compound that can undergo spontaneous decomposition to form toxic byproducts. Therefore, proper handling and storage are critical to prevent unintended exposure and ensure its stability.
In conclusion, D2-N-Nitroso desmethyldoxycycline is a promising compound that may have future applications in both antibacterial therapy and cancer treatment. Further research and development are needed to fully explore its potential and ensure its safety for human use.
